This study characterized the plasma lipoproteins of familial hyperalphalipoproteinemic patients with or without deficiency of cholesteryl ester transfer protein (CETP) activity. The subjects with CETP deficiency have increased levels of apolipoprotein (apo) E. The increased concentration of apo E in these subjects was correlated to the appearance of apo E-rich high density lipoproteins (HDL). Sodium dodecyl sulfate-polyacrylamide gel analysis revealed that these lipoproteins contained predominantly the apo E (82%) and little amount of apo A-I (18%). These apo E-rich HDL displayed a much higher affinity than human LDL in binding to LDL receptors on human fibroblasts. Furthermore, 3.5 times fewer apo E-rich HDL than LDL were required to saturate the receptors on fibroblasts. These data indicated that the apo E-rich HDL in CETP-deficient human subjects contained multiple copies of apo E and bound to the LDL receptor through multiple interactions. The apo E-rich HDL, with similar properties as cholesterol-induced apo E HDLc, were not detectable in normal human subjects or in hyperalphalipoproteinemic subjects with normal CETP activity. The apo E-containing HDL in the latter subjects were smaller and contained only small amounts of apo E (14%). The difference in apo E-containing HDL in these subjects suggests a correlation between CETP level and the appearance of apo E-rich HDL.
S Yamashita, D L Sprecher, N Sakai, Y Matsuzawa, S Tarui, D Y Hui
Title and authors | Publication | Year |
---|---|---|
Endothelial Function in Dyslipidemia: Roles of LDL-Cholesterol, HDL-Cholesterol and Triglycerides.
Higashi Y |
Cells | 2023 |
HDL Receptor in Schistosoma japonicum Mediating Egg Embryonation: Potential Molecular Basis for High Prevalence of Cholesteryl Ester Transfer Protein Deficiency in East Asia.
Yokoyama S |
Frontiers in Cell and Developmental Biology | 2022 |
Dalcetrapib and anacetrapib increase apolipoprotein E-containing HDL in rabbits and humans
Brodeur MR, Rhainds D, Charpentier D, Boulé M, Mihalache-Avram T, Mecteau M, Brand G, Pedneault-Gagnon V, Fortier A, Niesor EJ, Rhéaume E, Maugeais C, Tardif JC |
Journal of lipid research | 2022 |
Is a High HDL-Cholesterol Level Always Beneficial?
B Franczyk, J Rysz, J Ławiński, M Rysz-Górzyńska, A Gluba-Brzózka |
Biomedicines | 2021 |
Role of Genetics in Preventive Cardiology: Focused on Dyslipidemia
SH Lee |
Korean Circulation Journal | 2021 |
The hepatic WASH complex is required for efficient plasma LDL and HDL cholesterol clearance
Melinde Wijers, Paolo Zanoni, Nalan Liv, Dyonne Y. Vos, Michelle Y Jäckstein, Marieke Smit, Sanne Wilbrink, Justina C. Wolters, Ydwine Y.T. van der Veen, N.C.A. Huijkman, Daphne Dekker, Niels J Kloosterhuis, Theo H. van Dijk, Daniel Billadeau, Folkert Kuipers, Judith Klumperman, Arnold von Eckardstein, Jan Albert Kuivenhoven, Bart van de Sluis |
JCI Insight | 2019 |
Comparing Data-Independent Acquisition and Parallel Reaction Monitoring in Their Abilities To Differentiate High-Density Lipoprotein Subclasses
AR Silva, MT Toyoshima, M Passarelli, PD Mascio, GE Ronsein |
Journal of Proteome Research | 2019 |
Association of extremely high levels of high-density lipoprotein cholesterol with endothelial dysfunction in men
Y Takaeko, S Matsui, M Kajikawa, T Maruhashi, S Kishimoto, H Hashimoto, Y Kihara, E Hida, K Chayama, C Goto, Y Aibara, FM Yusoff, K Noma, A Nakashima, Y Higashi |
Journal of Clinical Lipidology | 2019 |
Shotgun proteomic analysis reveals proteome alterations in HDL of patients with cholesteryl ester transfer protein deficiency
T Okada, T Ohama, K Takafuji, K Kanno, H Matsuda, M Sairyo, Y Zhu, A Saga, T Kobayashi, D Masuda, M Koseki, M Nishida, Y Sakata, S Yamashita |
Journal of Clinical Lipidology | 2019 |
FoxO Transcription Factors are Required for Hepatic HDL-Cholesterol Clearance
Samuel Lee, Markus Heine, Christian Schlein, Rajasekhar Ramakrishnan, Jing Liu, Gabriella Belnavis, Ido Haimi, Alexander W. Fischer, Henry Ginsberg, Joerg Heeren, Franz Rinninger, Rebecca A. Haeusler |
Journal of Clinical Investigation | 2018 |
Particle number analysis of lipoprotein subclasses by gel permeation HPLC in patients with cholesteryl ester transfer protein deficiency
T Okada, T Ohama, M Okazaki, K Kanno, H Matsuda, M Sairyo, Y Zhu, A Saga, T Kobayashi, D Masuda, M Koseki, M Nishida, Y Sakata, S Yamashita, P Aspichueta |
PloS one | 2018 |
Present therapeutic role of cholesteryl ester transfer protein inhibitors
N Ferri, A Corsini, CR Sirtori, M Ruscica |
Pharmacological research : the official journal of the Italian Pharmacological Society | 2018 |
A two-step homogeneous assay for apolipoprotein E-containing high-density lipoprotein-cholesterol
Y Takahashi, Y Ito, T Sakurai, N Wada, A Nagasaka, M Fujikawa, H Chiba, SP Hui |
Annals of Clinical Biochemistry | 2018 |
High density lipoprotein cholesterol and proteome in SR-B1 KO mice: lost in precipitation
S Contreras-Duarte, N Santander, R Birner-Gruenberger, C Wadsack, A Rigotti, D Busso |
Journal of Translational Medicine | 2018 |
Comparative studies of three cholesteryl ester transfer proteins and their interactions with known inhibitors
Z Wang, M Niimi, Q Ding, Z Liu, L Wang, J Zhang, J Xu, J Fan, I Tancevski |
PloS one | 2017 |
The role of paraoxonase 1 in regulating high-density lipoprotein functionality during aging
A Khalil, OK Simo, S Ikhlef, H Berrougui |
Canadian Journal of Physiology and Pharmacology | 2017 |
Apolipoprotein E-containing high-density lipoprotein (HDL) modifies the impact of cholesterol-overloaded HDL on incident coronary heart disease risk: A community-based cohort study
Y Qi, J Liu, W Wang, M Wang, F Zhao, J Sun, J Liu, D Zhao |
Journal of Clinical Lipidology | 2017 |
Deficiency of Cholesteryl Ester Transfer Protein Protects Against Atherosclerosis in RabbitsHighlights
J Zhang, M Niimi, D Yang, J Liang, J Xu, T Kimura, AV Mathew, Y Guo, Y Fan, T Zhu, J Song, R Ackermann, Y Koike, A Schwendeman, L Lai, S Pennathur, M Garcia-Barrio, J Fan, YE Chen |
Arteriosclerosis, thrombosis, and vascular biology | 2017 |
Development of homogeneous assay for simultaneous measurement of apoE-deficient, apoE-containing, and total HDL-cholesterol
Y Takahashi, Y Ito, N Wada, A Nagasaka, M Fujikawa, T Sakurai, R Shrestha, SP Hui, H Chiba |
Clinica Chimica Acta | 2016 |
Analysis of lipoprotein profiles of healthy cats by gel-permeation high-performance liquid chromatography
H MIZUTANI, T SAKO, H OKUDA, N ARAI, K KURIYAMA, A MORI, I YOSHIMURA, H KOYAMA |
Journal of Veterinary Medical Science | 2016 |
Unique Features of High-Density Lipoproteins in the Japanese: In Population and in Genetic Factors
S Yokoyama |
Nutrients | 2015 |
Prevention of fatal hepatic complication in schistosomiasis by inhibition of CETP
Shinji Yokoyama, Kuniko Okumura-Noji, Rui Lu |
Journal of Biomedical Research | 2015 |
A potential screening factor for accumulation of cholesteyl ester transfer protein deficiency in East Asia: Schistosoma japonicum
S Yokoyama |
Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids | 2014 |
Reference Module in Biomedical Sciences
DL Sackett, RB Haynes |
2014 | |
Modulation of lipid metabolism with the overexpression of NPC1L1 in mouse liver[S]
M Kurano, M Hara, K Tsuneyama, K Okamoto, N Iso-O, T Matsushima, K Koike, K Tsukamoto |
Journal of lipid research | 2012 |
Lecithin:cholesterol acyltransferase: old friend or foe in atherosclerosis?
S Kunnen, MV Eck |
Journal of lipid research | 2012 |
Methods in Enzymology
JD Stone, AS Chervin, DH Aggen, DM Kranz |
Protein Engineering for Therapeutics Part B | 2012 |
Cholestasis Causes Discrepancy in HDL-Cholesterol Levels Measured Using Various Methods
S Kim, S Chun, W Lee, GS Kim, WK Min |
Laboratory Medicine Online | 2012 |
Lecithin:cholesterol acyltransferase: old friend or foe in atherosclerosis?
S Kunnen, MV Eck |
Journal of lipid research | 2012 |
HDL Measures, Particle Heterogeneity, Proposed Nomenclature, and Relation to Atherosclerotic Cardiovascular Events
RS Rosenson, HB Brewer, MJ Chapman, S Fazio, MM Hussain, A Kontush, RM Krauss, JD Otvos, AT Remaley, EJ Schaefer |
Clinical chemistry | 2011 |
Different effects of compounds decreasing cholesteryl ester transfer protein activity on lipoprotein metabolism
EJ Niesor |
Current Opinion in Lipidology | 2011 |
Anacetrapib, a Novel CETP Inhibitor: Pursuing a New Approach to Cardiovascular Risk Reduction
DE Gutstein, R Krishna, D Johns, HK Surks, HM Dansky, S Shah, YB Mitchel, J Arena, JA Wagner |
Clinical Pharmacology & Therapeutics | 2011 |
Cholesterol Efflux Potential and Antiinflammatory Properties of High-Density Lipoprotein After Treatment With Niacin or Anacetrapib
L Yvan-Charvet, J Kling, T Pagler, H Li, B Hubbard, T Fisher, CP Sparrow, AK Taggart, AR Tall |
Arteriosclerosis, thrombosis, and vascular biology | 2010 |
The HDL Handbook
NJ Hime |
The HDL Handbook | 2010 |
Formes rares de dyslipidémies génétiques
G Luc |
EMC - Endocrinologie - Nutrition | 2010 |
Association of ApoE and HDL-C with cardiovascular and cerebrovascular disease: potential benefits of LDL-apheresis therapy
PM Moriarty |
Clinical Lipidology | 2009 |
Pharmacokinetic, Pharmacodynamic, and Safety Profile of a New Cholesteryl Ester Transfer Protein Inhibitor in Healthy Human Subjects
R Wolk, D Chen, RW Clark, J Mancuso, PL Barclay |
Clinical Pharmacology & Therapeutics | 2009 |
Lessons Learned from the Investigation of Lipid Level Management to Understand its Impact in Atherosclerotic Events (ILLUMINATE) Trial
P Barter |
The American Journal of Cardiology | 2009 |
Peroxisome Proliferator-Activated Receptor α Agonists Regulate Cholesterol Ester Transfer Protein
TP Beyer, Y Chen, RK Porter, D Lu, RJ Schmidt, NB Mantlo, RJ Konrad, G Cao |
Lipids | 2008 |
HDL, ABC Transporters, and Cholesterol Efflux: Implications for the Treatment of Atherosclerosis
AR Tall, L Yvan-Charvet, N Terasaka, T Pagler, N Wang |
Cell Metabolism | 2008 |
Decreased post-prandial triglyceride response and diminished remnant lipoprotein formation in cholesteryl ester transfer protein (CETP) deficiency
A Inazu, K Nakajima, T Nakano, M Niimi, M Kawashiri, A Nohara, J Kobayashi, H Mabuchi |
Atherosclerosis | 2008 |
Functional LCAT deficiency in human apolipoprotein A-I transgenic, SR-BI knockout mice
JY Lee, RM Badeau, A Mulya, E Boudyguina, AK Gebre, TL Smith, JS Parks |
Journal of lipid research | 2007 |
HDL from CETP deficient subjects shows enhanced ability to promote cholesterol efflux from macrophages in an apoE- and ABCG1-dependent pathway
Fumihiko Matsuura, Nan Wang, Wengen Chen, Xian-Cheng Jiang, Alan R. Tall |
Journal of Clinical Investigation | 2006 |
Putting cholesterol in its place: apoE and reverse cholesterol transport
RW Mahley, Y Huang, KH Weisgraber |
Journal of Clinical Investigation | 2006 |
Altered lipid, apolipoprotein, and lipoprotein profiles in inflammatory bowel disease: consequences on the cholesterol efflux capacity of serum using Fu5AH cell system
BR Piquer, H Nazih, A Bourreille, JP Segain, JM Huvelin, JP Galmiche, JM Bard |
Metabolism | 2006 |
Effect of cholesteryl ester transfer protein (CETP) expression on diet-induced hyperlipidemias in transgenic rats
Z Zak, T Gautier, L Dumont, D Masson, V Deckert, L Duverneuil, JP de Barros, NL Guern, M Schneider, P Moulin, A Bataillard, L Lagrost |
Atherosclerosis | 2005 |
Inhibition of cholesteryl ester transfer protein activity: A new therapeutic approach to raising high-density lipoprotein
DJ Rader |
Current Atherosclerosis Reports | 2004 |
Pharmacological modulation of cholesteryl ester transfer protein, a new therapeutic target in atherogenic dyslipidemia
WL Goff, M Guerin, MJ Chapman |
Pharmacology & Therapeutics | 2004 |
Scavenger receptor type BI potentiates reverse cholesterol transport system by removing cholesterol ester from HDL
M Kinoshita, M Fujita, S Usui, Y Maeda, M Kudo, D Hirota, T Suda, M Taki, M Okazaki, T Teramoto |
Atherosclerosis | 2004 |
Molecular Mechanisms of Cholesteryl Ester Transfer Protein Deficiency in Japanese
M Nagano, S Yamashita, K Hirano, M Takano, T Maruyama, M Ishihara, Y Sagehashi, T Kujiraoka, K Tanaka, H Hattori, N Sakai, N Nakajima, T Egashira, Y Matsuzawa |
Journal of Atherosclerosis and Thrombosis | 2004 |
Hypertriglyceridemia in pregnancy does not contribute to the enhanced formation of remnant lipoprotein particles
M Okazaki, S Usui, K Tokunaga, Y Nakajima, S Takeichi, T Nakano, K Nakajima |
Clinica Chimica Acta | 2004 |
Emerging strategies and applications of pharmacogenomics
PM Milos, AB Seymour |
Human genomics | 2004 |
HDL: The Metabolism, Function, and Therapeutic Importance
M Wang, MR Briggs |
Chemical Reviews | 2003 |
Prevalence and phenotypic spectrum of cholesteryl ester transfer protein gene mutations in Japanese hyperalphalipoproteinemia
T Maruyama, N Sakai, M Ishigami, K Hirano, T Arai, S Okada, E Okuda, A Ohya, N Nakajima, K Kadowaki, E Fushimi, S Yamashita, Y Matsuzawa |
Atherosclerosis | 2003 |
Enlargement of High Density Lipoprotein in Mice via Liver X Receptor Activation Requires Apolipoprotein E and Is Abolished by Cholesteryl Ester Transfer Protein Expression
XC Jiang, TP Beyer, Z Li, J Liu, W Quan, RJ Schmidt, Y Zhang, WR Bensch, PI Eacho, G Cao |
The Journal of biological chemistry | 2003 |
Apolipoprotein composition of HDL in cholesteryl ester transfer protein deficiency
BF Asztalos, KV Horvath, K Kajinami, C Nartsupha, CE Cox, M Batista, EJ Schaefer, A Inazu, H Mabuchi |
Journal of lipid research | 2003 |
Structural and functional properties of human plasma high density-sized lipoprotein containing only apoE particles
L Krimbou, M Marcil, H Chiba, J Genest |
Journal of lipid research | 2003 |
Cholesteryl Ester Transfer Protein: A Novel Target for Raising HDL and Inhibiting Atherosclerosis
PJ Barter, HB Brewer, MJ Chapman, CH Hennekens, DJ Rader, AR Tall |
Arteriosclerosis, thrombosis, and vascular biology | 2003 |
Lexikon der Syndrome und Fehlbildungen
R Witkowski, O Prokop, E Ullrich, G Thiel |
2003 | |
Unique character and metabolism of high density lipoprotein (HDL) in fetus
H Nagasaka, H Chiba, H Kikuta, H Akita, Y Takahashi, H Yanai, SP Hui, H Fuda, H Fujiwara, K Kobayashi |
Atherosclerosis | 2002 |
A major gene influences variation in large HDL particles and their response to diet in baboons
DL Rainwater, CM Kammerer, LA Cox, J Rogers, KD Carey, B Dyke, MC Mahaney, HC McGill, JL VandeBerg |
Atherosclerosis | 2002 |
Advances in Cell Aging and Gerontology
T Fülöp, K Hirokawa, G Dupuis, A Larbi, G Pawelec |
Advances in Cell Aging and Gerontology | 2002 |
Hugh Sinclair Lecture: The regulation and remodelling of HDL by plasma factors
PJ Barter |
Atherosclerosis Supplements | 2002 |
Phospholipid Transfer Protein Is Regulated by Liver X Receptors in Vivo
G Cao, TP Beyer, XP Yang, RJ Schmidt, Y Zhang, WR Bensch, RF Kauffman, H Gao, TP Ryan, Y Liang, PI Eacho, XC Jiang |
The Journal of biological chemistry | 2002 |
Expression of simian CETP in normolipidemic Fisher rats has a profound effect on large sized apoE-containing HDL
Z Zak, L Lagrost, T Gautier, D Masson, V Deckert, L Duverneuil, JP de Barros, NL Guern, L Dumont, M Schneider, V Risson, P Moulin, D Autran, G Brooker, J Sassard, A Bataillard |
Journal of lipid research | 2002 |
Studies on the plasma lipid profiles, and LCAT and CETP activities according to hyperlipoproteinemia phenotypes (HLP)
M Lee, JQ Kim, J Kim, H Oh, M Park |
Atherosclerosis | 2001 |
Expression of cholesteryl ester transfer protein in human atherosclerotic lesions and its implication in reverse cholesterol transport
Z Zhang, S Yamashita, K Hirano, Y Nakagawa-Toyama, A Matsuyama, M Nishida, N Sakai, M Fukasawa, H Arai, J Miyagawa, Y Matsuzawa |
Atherosclerosis | 2001 |
Significance of a Polymorphism (G-^|^gt;A transition) in the -75 Position of the Apolipoprotein A-I Gene Promoter on Serum High Density Lipoprotein-Cholesterol Levels in Japanese Hyperlipidemic Subjects
J Tashiro, N Morisaki, J Kobayashi, H Bujo, T Kanzaki, S Murano, Y Saito |
Journal of Atherosclerosis and Thrombosis | 2001 |
Molecular mechanisms, lipoprotein abnormalities and atherogenicity of hyperalphalipoproteinemia
S Yamashita, T Maruyama, K Hirano, N Sakai, N Nakajima, Y Matsuzawa |
Atherosclerosis | 2000 |
Molecular biology and pathophysiological aspects of plasma cholesteryl ester transfer protein
S Yamashita |
Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids | 2000 |
Pros and cons of inhibiting cholesteryl ester transfer protein
K Hirano, S Yamashita, Y Matsuzawa |
Current Opinion in Lipidology | 2000 |
Lipoprotein Metabolism and Atherogenesis
T Kita, M Yokode |
2000 | |
Cholesteryl ester transfer protein corrects dysfunctional high density lipoproteins and reduces aortic atherosclerosis in lecithin cholesterol acyltransferase transgenic mice
B Föger, M Chase, MJ Amar, BL Vaisman, RD Shamburek, B Paigen, J Fruchart-Najib, JA Paiz, CA Koch, RF Hoyt, HB Brewer, S Santamarina-Fojo |
The Journal of biological chemistry | 1999 |
Expression of Human Scavenger Receptor Class B Type I in Cultured Human Monocyte-Derived Macrophages and Atherosclerotic Lesions
K Hirano, S Yamashita, Y Nakagawa, T Ohya, F Matsuura, K Tsukamoto, Y Okamoto, A Matsuyama, K Matsumoto, J Miyagawa, Y Matsuzawa |
Circulation research | 1999 |
Advances in Protein Chemistry
CM Silva, J Isgaard, MO Thorner |
Advances in Protein Chemistry | 1998 |
Plasma lipid transfer proteins, high-density lipoproteins, and reverse cholesterol transport
M Dammerman, LA Sandkuijl, JL Halaas, W Chung, JL Breslow |
Annual Review of Nutrition | 1998 |
Plasma lipid transfer proteins, high-density lipoproteins, and reverse cholesterol transport
M Dammerman, LA Sandkuijl, JL Halaas, W Chung, JL Breslow |
Annual Review of Nutrition | 1998 |
Fish-eye disease: Structural and in vivo metabolic abnormalities of high-density lipoproteins
L Elkhalil, Z Majd, R Bakir, O Perez-Mendez, G Castro, P Poulain, B Lacroix, N Duhal, JC Fruchart, G Luc |
Metabolism | 1997 |
The Role of Cholesteryl Ester Transfer Protein and Phospholipid Transfer Protein in the Remodeling of Plasma High-Density Lipoproteins
L Lagrost |
Trends in Cardiovascular Medicine | 1997 |
Cholesteryl Ester Transfer Protein Activity Enhances Plasma Cholesteryl Ester Formation: Studies in CETP Transgenic Mice and Human Genetic CETP Deficiency
HC Oliveira, L Ma, R Milne, SM Marcovina, A Inazu, H Mabuchi, AR Tall |
Arteriosclerosis, thrombosis, and vascular biology | 1997 |
Genetic Cholesteryl Ester Transfer Protein Deficiency Is Extremely Frequent in the Omagari Area of Japan: Marked Hyperalphalipoproteinemia Caused by CETP Gene Mutation Is Not Associated With Longevity
K Hirano, S Yamashita, N Nakajima, T Arai, T Maruyama, Y Yoshida, M Ishigami, N Sakai, K Kameda-Takemura, Y Matsuzawa |
Arteriosclerosis, thrombosis, and vascular biology | 1997 |
Quantitative and compositional changes in high density lipoprotein subclasses in patients with various genotypes of cholesteryl ester transfer protein deficiency
H Chiba, H Akita, K Tsuchihashi, SP Hui, Y Takahashi, H Fuda, H Suzuki, H Shibuya, M Tsuji, K Kobayashi |
Journal of lipid research | 1997 |
Characterization of human plasma apolipoprotein E-containing lipoproteins in the high density lipoprotein size range: focus on pre-beta1-LpE, pre-beta2-LpE, and alpha-LpE
L Krimbou, M Tremblay, J Davignon, JS Cohn |
Journal of lipid research | 1997 |
Opposite effects of bezafibrate and gemfibrozil in both normal and hypertriglyceridemic rats
BR Krause, BC Barnett, AD Essenburg, KA Kieft, BJ Auerbach, R Bousley, R Stanfield, RS Newton, CL Bisgaier |
Atherosclerosis | 1996 |
Effect of lipid transfer proteins on lipoprotein lipase induced transformation of VLDL and HDL
SJ Murdoch, WC Breckenridge |
Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism | 1996 |
Molecular Disorders of Cholesteryl Ester Transfer Protein
S Yamashita, T Arai, K Hirano, N Sakai, M Ishigami, N Nakajima, Y Matsuzawa |
Journal of Atherosclerosis and Thrombosis | 1996 |
Drugs Affecting Lipid Metabolism
AM Gotto, R Paoletti, LC Smith, AL Catapano, AS Jackson |
1996 | |
A novel nonsense mutation (G181X) in the human cholesteryl ester transfer protein gene in Japanese hyperalphalipoproteinemic subjects
T Arai, S Yamashita, N Sakai, K Hirano, S Okada, M Ishigami, T Maruyama, M Yamane, H Kobayashi, S Nozaki, T Funahashi, K Kameda-Takemura, N Nakajima, Y Matsuzawa |
Journal of lipid research | 1996 |
Exon 10 skipping caused by intron 10 splice donor site mutation in cholesteryl ester transfer protein gene results in abnormal downstream splice site selection
N Sakai, S Santamarina-Fojo, S Yamashita, Y Matsuzawa, HB Brewer |
Journal of lipid research | 1996 |
Increased catabolic rate of low density lipoproteins in humans with cholesteryl ester transfer protein deficiency
K Ikewaki, M Nishiwaki, T Sakamoto, T Ishikawa, T Fairwell, LA Zech, M Nagano, H Nakamura, HB Brewer, DJ Rader |
Journal of Clinical Investigation | 1995 |
Remodelling of lipoproteins in transgenic mice expressing human cholesteryl ester transfer protein
J Dinchuk |
Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism | 1995 |
Cholesteryl ester transfer protein inhibition in hypercholesterolemic hamsters: Kinetics of apoprotein changes
SH Zuckerman, GF Evans |
Lipids | 1995 |
Plasma cholesteryl ester transfer protein and high-density lipoproteins: new insights from molecular genetic studies
AR Tall |
Journal of Internal Medicine | 1995 |
Characterization of High-density Apolipoprotein Particles A-I and A-I:A-II Isolated from Humans with Cholesteryl Ester Transfer Protein Deficiency
N Duverger, D Rader, K Ikewaki, M Nishiwaki, T Sakamoto, T Ishikawa, M Nagano, H Nakamura, HB Brewer |
European Journal of Biochemistry | 1995 |
Section Review—Cardiovascular & Renal: Emerging Therapies in Atherosclerosis
BR Krause, DR Sliskovic, TM Bocan |
Expert Opinion on Investigational Drugs | 1995 |
Frequency of exon 15 missense mutation (442D:G) in cholesteryl ester transfer protein gene in hyperalphalipoproteinemic Japanese subjects
N Sakai, S Yamashita, K Hirano, M Menju, T Arai, K Kobayashi, M Ishigami, Y Yoshida, T Hoshino, N Nakajima, K Kameda-Takemura, Y Matsuzawa |
Atherosclerosis | 1995 |
Decreased affinity of low density lipoprotein (LDL) particles for LDL receptors in patients with cholesteryl ester transfer protein deficiency
N Sakai, S Yamashita, KI Hirano, M Ishigami, T Arai, K Kobayashi, T Funahashi, Y Matsuzawa |
European Journal of Clinical Investigation | 1995 |
Enzyme-linked immunosorbent assay for cholesteryl ester transfer protein in human serum
T Sato, M Fukasawa, M Kinoshita, H Arai, T Saeki, T Naraki, Y Iwasaki, T Teramoto, K Takahashi, Y Saito, K Inoue |
Clinica Chimica Acta | 1995 |
Triglycerides Are Major Determinants of Cholesterol Esterification/Transfer and HDL Remodeling in Human Plasma
T Murakami, S Michelagnoli, R Longhi, G Gianfranceschi, F Pazzucconi, L Calabresi, CR Sirtori, G Franceschini |
Arteriosclerosis, thrombosis, and vascular biology | 1995 |
Apolipoprotein B and E Basic Amino Acid Clusters Influence Low-Density Lipoprotein Association with Lipoprotein Lipase Anchored to the Subendothelial Matrix
U Saxena, BJ Auerbach, E Ferguson, J Wölle, YL Marcel, KH Weisgraber, RA Hegele, CL Bisgaier |
Arteriosclerosis, thrombosis, and vascular biology | 1995 |
Atherosclerotic Disease in Marked Hyperalphalipoproteinemia: Combined Reduction of Cholesteryl Ester Transfer Protein and Hepatic Triglyceride Lipase
K Hirano, S Yamashita, Y Kuga, N Sakai, S Nozaki, S Kihara, T Arai, K Yanagi, S Takami, M Menju, M Ishigami, Y Yoshida, K Kameda-Takemura, K Hayashi, Y Matsuzawa |
Arteriosclerosis, thrombosis, and vascular biology | 1995 |
Evidence for Nonesterified Fatty Acids as Modulators of Neutral Lipid Transfers in Normolipidemic Human Plasma
L Lagrost, E Florentin, V Guyard-Dangremont, A Athias, H Gandjini, C Lallemant, P Gambert |
Arteriosclerosis, thrombosis, and vascular biology | 1995 |
Cholesteryl ester transfer protein inhibition by PD 140195
CL Bisgaier, AD Essenburg, LL Minton, R Homan, CJ Blankley, A White |
Lipids | 1994 |
Drug control of reverse cholesterol transport
G Franceschini, JP werba, L Calabresi |
Pharmacology & Therapeutics | 1994 |
Regulation of cholesteryl ester transfer protein (CETP) activity: review of in vitro and in vivo studies
L Lagrost |
Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism | 1994 |
Determination of Apolipoprotein E in High Density Lipoprotein Fraction by Immunofixation Method and Turbidimetric Immunoassay After Precipitation
Y Okamoto, H Tsujii, Y Haga, S Tanaka, H Nakano |
Journal of Atherosclerosis and Thrombosis | 1994 |
Properties of Human Plasma Lipid Transfer Protein in Aqueous Solution and at Interfaces
T Ohnishi, LD Hicks, K Oikawa, CM Kay, S Yokoyama |
Biochemistry | 1994 |
Increased plasma cholesteryl ester transfer protein in obese subjects. A possible mechanism for the reduction of serum HDL cholesterol levels in obesity
T Arai, S Yamashita, K Hirano, N Sakai, K Kotani, S Fujioka, S Nozaki, Y Keno, M Yamane, E Shinohara |
Arteriosclerosis Thrombosis and Vascular Biology | 1994 |
In vivo metabolism of apolipoproteins A-I and E in patients with abetalipoproteinemia: implications for the roles of apolipoproteins B and E in HDL metabolism
K Ikewaki, DJ Rader, LA Zech, HB Brewer |
Journal of lipid research | 1994 |
Identification of apolipoprotein B-100 low density lipoproteins, apolipoprotein B-48 remnants, and apolipoprotein E-rich high density lipoproteins in the mouse
HV de Silva, J Más-Oliva, JM Taylor, RW Mahley |
Journal of lipid research | 1994 |
Inhibition of cholesteryl ester transfer protein in normocholesterolemic and hypercholesterolemic hamsters: effects on HDL subspecies, quantity, and apolipoprotein distribution
GF Evans, WR Bensch, LD Apelgren, D Bailey, RF Kauffman, TF Bumol, SH Zuckerman |
Journal of lipid research | 1994 |
Dietary regulation of cholesterol esterase mRNA level in rat pancreas
J Brodt-Eppley, DY Hui |
Journal of lipid research | 1994 |
Apolipoprotein A-I metabolism in cholesteryl ester transfer protein transgenic mice. Insights into the mechanisms responsible for low plasma high density lipoprotein levels
GW Melchior, CK Castle, RW Murray, WL Blake, DM Dinh, KR Marotti |
The Journal of biological chemistry | 1994 |
Delayed catabolism of high density lipoprotein apolipoproteins A-I and A-II in human cholesteryl ester transfer protein deficiency
K Ikewaki, DJ Rader, T Sakamoto, M Nishiwaki, N Wakimoto, JR Schaefer, T Ishikawa, T Fairwell, LA Zech, H Nakamura |
Journal of Clinical Investigation | 1993 |
A missense mutation in the cholesteryl ester transfer protein gene with possible dominant effects on plasma high density lipoproteins
K Takahashi, XC Jiang, N Sakai, S Yamashita, K Hirano, H Bujo, H Yamazaki, J Kusunoki, T Miura, P Kussie |
Journal of Clinical Investigation | 1993 |
High density lipoprotein deficiency with xanthomas. A defect in reverse cholesterol transport caused by a point mutation in the apolipoprotein A-I gene
KJ Lackner, H Dieplinger, G Nowicka, G Schmitz |
Journal of Clinical Investigation | 1993 |
Decrease of hepatic triglyceride lipase levels and increase of cholesteryl ester transfer protein levels in patients with primary biliary cirrhosis: Relationship to abnormalities in high-density lipoprotein
H Hiraoka, S Yamashita, Y Matsuzawa, M Kubo, S Nozaki, N Sakai, KI Hirano, S Kawata, S Tarui |
Hepatology | 1993 |
Elevated high density lipoprotein concentrations in heart transplant recipients are related to impaired plasma cholesteryl ester transfer and hepatic lipase activity
V Atger, T Leclerc, M Cambillau, R Guillemain, C Marti, N Moatti, A Girard |
Atherosclerosis | 1993 |
Function of cholesteryl ester transfer protein in reverse cholesterol transport
R McPherson |
CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne | 1993 |
Mechanisms of high-density lipoprotein reduction after probucol treatment: Changes in plasma cholesterol esterification/transfer and lipase-activities
G Chiesa, S Michelagnoli, M Cassinotti, G Gianfranceschi, JP Werba, F Pazzucconi, CR Sirotori, G Franceschini |
Metabolism | 1993 |
Cholesteryl ester transfer activity in lipoprotein lipase deficiency and other primary hypertriglyceridemias
A Iglesias, JA Contreras, M Martinez-Pardo, A Entrala, E Herrera, MA Lasunción |
Clinica Chimica Acta | 1993 |
Frequency of intron 14 splicing defect of cholesteryl ester transfer protein gene in the Japanese general population — relation between the mutation and hyperalphalipoproteinemia
K Hirano, S Yamashita, T Funahashi, N Sakai, M Menju, M Ishigami, H Hiraoka, K Kameda-Takemura, K Tokunaga, T Hoshino, K Kumasaka, K Kawano, Y Matsuzawa |
Atherosclerosis | 1993 |
Unusual high-density lipoprotein subclass distribution during late pregnancy
K Silliman, AR Tall, N Kretchmer, TM Forte |
Metabolism | 1993 |
Activation of human plasma lipid transfer protein by apolipoproteins
T Ohnishi, S Yokoyama |
Biochemistry | 1993 |
Determination of lipid transfer inhibitor protein activity in human lipoprotein-deficient plasma
RE Morton, JV Steinbrunner |
Arteriosclerosis Thrombosis and Vascular Biology | 1993 |
Advances in Human Genetics 21
H Harris, K Hirschhorn |
1993 | |
Apolipoprotein E modulates low density lipoprotein retention by lipoprotein lipase anchored to the subendothelial matrix
U Saxena, E Ferguson, CL Bisgaier |
The Journal of biological chemistry | 1993 |
Adipose tissue cholesteryl ester transfer protein mRNA in response to probucol treatment: cholesterol and species dependence
EM Quinet, P Huerta, D Nancoo, AR Tall, YL Marcel, R McPherson |
Journal of lipid research | 1993 |
Plasma cholesteryl ester transfer protein
AR Tall |
Journal of lipid research | 1993 |
An interaction between the human cholesteryl ester transfer protein (CETP) and apolipoprotein A-I genes in transgenic mice results in a profound CETP-mediated depression of high density lipoprotein cholesterol levels
T Hayek, T Chajek-Shaul, A Walsh, LB Agellon, P Moulin, AR Tall, JL Breslow |
Journal of Clinical Investigation | 1992 |
Metabolic and genetic control of HDL cholesterol levels
AR Tall |
Journal of Internal Medicine | 1992 |
Low-density lipoproteins in hyperalphalipoproteinemic heavy alcohol drinkers have reduced affinity for the low-density lipoprotein receptor
K Hirano, S Yamashita, N Sakai, H Hiraoka, Y Ueyama, T Funahashi, Y Matsuzawa |
Clinical Biochemistry | 1992 |
The CCAAT/enhancer-binding protein trans-activates the human cholesteryl ester transfer protein gene promoter
LB Agellon, P Zhang, XC Jiang, L Mendelsohn, AR Tall |
The Journal of biological chemistry | 1992 |
Probucol increases cholesteryl ester transfer protein activity in hypercholesterolaemic patients
G Franceschini, G Chiesa, CR Sirtori |
European Journal of Clinical Investigation | 1991 |
Reverse cholesterol transport: Physiology and pharmacology
G Franceschini, P Maderna, CR Sirtori |
Atherosclerosis | 1991 |
The role of the cholesteryl ester transfer protein in lipoprotein metabolism
TL Swenson |
Diabetes / Metabolism Reviews | 1991 |
Role of cholesteryl ester transfer protein in reverse cholesterol transport
R Mcpherson, Y Marcel |
Clinical Cardiology | 1991 |
HDL heterogeneity and coronary heart disease
C Fievet, JC Fruchart |
Diabetes / Metabolism Reviews | 1991 |
Characterization of plasma lipoproteins in patients heterozygous for human plasma cholesteryl ester transfer protein (CETP) deficiency: Plasma CETP regulates high-density lipoprotein concentration and composition
S Yamashita, DY Hui, JR Wetterau, DL Sprecher, JA Harmony, N Sakai, Y Matsuzawa, S Tarui |
Metabolism | 1991 |
1. Pathophysiology of triglyceride-rich particles
Y Stein, RJ Havel |
The American Journal of Cardiology | 1991 |
Detection of two species of low density lipoprotein particles in cholesteryl ester transfer protein deficiency
N Sakai, Y Matsuzawa, K Hirano, S Yamashita, S Nozaki, Y Ueyama, M Kubo, S Tarui |
Arteriosclerosis Thrombosis and Vascular Biology | 1991 |
Plasma concentrations of cholesteryl ester transfer protein in hyperlipoproteinemia. Relation to cholesteryl ester transfer protein activity and other lipoprotein variables
R McPherson, CJ Mann, AR Tall, M Hogue, L Martin, RW Milne, YL Marcel |
Arteriosclerosis Thrombosis and Vascular Biology | 1991 |
Reduced high density lipoprotein cholesterol in human cholesteryl ester transfer protein transgenic mice
LB Agellon, A Walsh, T Hayek, P Moulin, XC Jiang, SA Shelanski, JL Breslow, AR Tall |
The Journal of biological chemistry | 1991 |
New Comprehensive Biochemistry
S Yamamoto |
New Comprehensive Biochemistry | 1983 |